Literature DB >> 22363385

A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia.

Hyun-Sung Shin1, Tae Soo Kang.   

Abstract

Aplastic anemia is a condition in which the bone marrow fails to produce adequate numbers of peripheral blood elements. The incidences of atherosclerosis and myocardial infarction in patients with congenital coagulation disorders and chronic thrombocytopenia are very low. In this paper, a case of late stent thrombosis within a drug-eluting stent occurring after platelet transfusion in a patient with aplastic anemia is presented. The authors' observations emphasize the risks of platelet transfusion and the authors' support withholding such a treatment unless vitally indicated, in patients with coronary artery stent implantation and even in those on dual antiplatelet therapy.

Entities:  

Keywords:  Aplastic, anemia; Platelet transfusion; Stent; Thrombosis

Year:  2012        PMID: 22363385      PMCID: PMC3283756          DOI: 10.4070/kcj.2012.42.1.54

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  11 in total

1.  Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)

Authors:  R Paolini; F Fabris; G Cella
Journal:  Am J Hematol       Date:  2000-10       Impact factor: 10.047

2.  Thrombotic complications after intravenous immunoglobulin therapy in two patients.

Authors:  Geoffrey G Emerson; Christopher N Herndon; Antoine G Sreih
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

3.  [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link].

Authors:  Tomás C Méndez; Oscar Díaz; Lourdes Enríquez; José A Baz; Felipe Fernández; Javier Goicolea
Journal:  Rev Esp Cardiol       Date:  2004-08       Impact factor: 4.753

4.  Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.

Authors:  T Urano; K Sakakibara; A Rydzewski; S Urano; Y Takada; A Takada
Journal:  Thromb Haemost       Date:  1990-02-19       Impact factor: 5.249

Review 5.  Plasminogen activator inhibitor 1 and atherothrombosis.

Authors:  I Juhan-Vague; M C Alessi
Journal:  Thromb Haemost       Date:  1993-07-01       Impact factor: 5.249

6.  Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids.

Authors:  M Fisher; M Appleby; D Rittoo; L Cotter
Journal:  Br J Clin Pract       Date:  1996-06

7.  Plasminogen activator inhibitor-1, which is released from blood product transfusions, might be associated with (sub)acute thrombosis after coronary dilatation and stenting: a case report.

Authors:  Miso Sabovic; Simona Krzisnik Zorman
Journal:  Heart Vessels       Date:  2003-03       Impact factor: 2.037

8.  Guidelines on the use of intravenous immune globulin for hematologic conditions.

Authors:  David Anderson; Kaiser Ali; Victor Blanchette; Melissa Brouwers; Stephen Couban; Paula Radmoor; Lothar Huebsch; Heather Hume; Anne McLeod; Ralph Meyer; Catherine Moltzan; Susan Nahirniak; Stephen Nantel; Graham Pineo; Gail Rock
Journal:  Transfus Med Rev       Date:  2007-04

9.  Acute stent thrombosis in a patient with giant cell arteritis.

Authors:  Jason Andrade; Abdullah Al Ali; Jacqueline Saw; Graham C Wong
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

10.  Coronary stent occlusion after platelet transfusion: a case series.

Authors:  Alexander D Cornet; Lucas J Klein; A B Johan Groeneveld
Journal:  J Invasive Cardiol       Date:  2007-10       Impact factor: 2.022

View more
  1 in total

Review 1.  Towards increasing shelf life and haemostatic potency of stored platelet concentrates.

Authors:  Shailaja Hegde; Huzoor Akbar; Yi Zheng; Jose A Cancelas
Journal:  Curr Opin Hematol       Date:  2018-11       Impact factor: 3.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.